A Bayesian analysis of bisphosphonate effects in osteoporosis can now be
found at:
http://www3.interscience.wiley.com/cgi-bin/fulltext?ID=76506229&PLACEBO=IE.pdf
A Bayesian analysis of bisphosphonate effects and cost-effectiveness in
post-menopausal osteoporosis Ivar Aursnes MD, Geir Storvik PhD, Jørund
Gåsemyr PhD, Bent Natvig PhD Pharmacoepidemiology and Drug Safety
2000;9;501-10.
At 11:36 30.11.98 +0000, Nino Cartabellotta wrote:
>At 09.53 30/11/98 -0800, you wrote:
>>At my local health authority we're surprised that we can't find a really
>>good set of osteoporosis prevention/treatment guidleines to serve as a
>>starting point for our health improvement plan. We'd like a set that covers
>>primary prevention (e.g. children's diets), secondary prevention, lifestlye,
>>and "rationing" of expensive invesigations and drugs. Can anyone help?
>>thanks
>
>
>I alert you about some of guidelines of our database
>
>Osteoporosis Guidelines of Canadian Medical Association
>http://www.cma.ca/cpgs/osteocpg.htm
>
>Bisphosphonates (alendronate and etidronate) in the management of
osteoporosis
>Best L, Milne R Southampton: Wessex Institute for Health Research and
>Development 1998 DEC Report No. 79 [988897]
>http://www.epi.bris.ac.uk/rd/publicat/dec/dec79.htm
>
>Bone mineral density testing: does the evidence support its selective use
>in well
>women? Green C J, Bassett K, Foerster V, Kazanjian A Vancouver: B.C. Office
>of Health Technology Assessment, Centre for Health Services and Policy
>Research, University of British Columbia. 1997 BCOHTA 97:2T pp.188 [988411]
>http://www.chspr.ubc.ca//bcohta/pdf/bmd.pdf
>
>Give me a feedback
>Bests
>
>------------------------------------------------------------------
> Gruppo Italiano per la Medicina Basata sulle Evidenze
>------------------------------------------------------------------
>Antonino Cartabellotta, MD Phone:+39 091 407153
>Head of GIMBE Fax: +39 091 407153
>Passaggio L. da Vinci, 16 [log in to unmask]
>90145 - Palermo (Italy) www.gimbe.org
>------------------------------------------------------------------
> G I M B E
>------------------------------------------------------------------
>
>__________________________________________________________________
>EBM Niguarda Centre Phone: +39 02 64442864
>Office for Quality Assurance Fax: +39 02 64442319
>Niguarda Hospital
>Piazza Ospedale Maggiore, 3 20162 - Milan (Italy)
>__________________________________________________________________
>
>
Ivar Aursnes
Professor i klinisk farmakologi
Institutt for farmakoterapi, Det medisinske fakultet, UiO
Besøksadresse: Ullevål sykehus, bygning U, oppgang 1, 4.etasje
Postadresse: pb 1065 Blindern, 0316 Oslo
Telefon: 22119007
Faks: 22119013
email: [log in to unmask]
|